REPORT OUTLOOK
Market Size | CAGR | Dominating Region |
---|---|---|
132.64 billion | 3.9% | North America |
by Product and Service | by Application | by End User Industry |
---|---|---|
|
|
|
SCOPE OF THE REPORT
In-Vitro Diagnostics/IVD Market Overview
The global In-Vitro Diagnostics/IVD market is expected to grow at 3.9% CAGR from 2022 to 2029. It is expected to reach above USD 132.64 billion by 2029 from USD 95.16 billion in 2020.
In vitro diagnostics (IVD) encompasses a spectrum of medical examinations and procedures conducted using bodily fluids, tissues, or specimens obtained from patients outside their body. These analyses are conducted within controlled laboratory settings, employing specialized equipment and methodologies tailored for diagnostic purposes.
The global surge in the elderly demographic is anticipated to precipitate a notable rise in the incidence of age-related ailments. As per data from the United Nations Department of Economic and Social Affairs (UN DESA) in 2022, approximately 10% of the global population is aged 65 or older. This demographic segment is projected to expand to nearly 12% by 2030 and 16% by 2050.
ATTRIBUTE | DETAILS |
Study period | 2020-2029 |
Base year | 2021 |
Estimated year | 2022 |
Forecasted year | 2022-2029 |
Historical period | 2018-2020 |
Unit | Value (USD Billion) |
Segmentation | By Product and Service, By Technology, By Application, By End-User, By Region |
By Product and Service |
|
By Technology |
|
By Application | |
By Region |
|
With advancing age comes an increased susceptibility to various diseases; notably, nearly 80% of the elderly populace in the United States grapples with at least one chronic condition, according to the Centers for Disease Control and Prevention (CDC). Research conducted by the National Council On Aging (NCOA) reveals that 94.9% of adults aged 60 and above exhibit at least one chronic ailment, with 78.7% experiencing two or more concurrently.
Elevated blood cholesterol levels heighten the risk of heart disease, the foremost cause of mortality, and stroke, ranking as the fifth leading cause of death globally. Diabetes, another prevalent chronic ailment among the elderly, stems from endocrine irregularities exacerbated by age-related hormonal fluctuations. Consequently, the burgeoning geriatric demographic is anticipated to foster a surge in chronic condition prevalence worldwide, thereby stimulating growth within the IVD market.
In-Vitro Diagnostics/IVD Market Segment Analysis
The In-Vitro Diagnostics/IVD market is divided on the basis of Product and service, Technology, application and end user industry. On the basis of Product and service, In-Vitro Diagnostics/IVD market is segmented into Instrument, Kits. In 2020, the reagents & kits sector held the greatest share of the IVD market, accounting for 68.1 percent. The demand for reliable, specific, and speedier detection of chronic illnesses and genetic abnormalities in the early stages, as well as access to a wide range of reagents, are projected to fuel the expansion of this market.
On the basis of Technology, In-Vitro Diagnostics/IVD market is segmented into Immunoassay, MDx, Hematology, Urinalysis. In 2020, the immunoassay/immunochemistry sector will account for 31% of the IVD technologies market. The capacity of immunoassay/immunochemistry technologies to provide faster findings with high sensitivity and accuracy, as well as the rising preference for these technologies in clinical diagnostics over traditional methods, are all contributing to the growth of this market sector.
On the basis of Application, In-Vitro Diagnostics/IVD market is segmented into Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases. Infectious disorders would account for 34.1 percent of the IVD market in 2020. The increased frequency of infectious illnesses and multi-drug-resistant infectious diseases, as well as the growing demand for efficient diagnostic tools for these diseases, can be linked to this segment’s substantial share. During the projection period, however, the oncology section is expected to increase at the fastest rate of 6.6 percent. The expanding number of cancer patients throughout the world, the rising need for tailored therapy, and the availability of financing for cancer research are all propelling the industry forward.
On the basis of End use Industry, In-Vitro Diagnostics/IVD market is segmented into Hospitals, Clinical laboratories, Point-of-care testing centers, Academic institutes, Patients, Other. Hospital laboratories will account for 47 percent of the IVD market in 2020, followed by clinical laboratories (23.8 percent) and point-of-care testing centers (13 percent). In hospitals, a variety of diagnostic tests are performed. The acquisition of smaller physician practices and groups by hospitals is becoming a noteworthy trend in the US healthcare business; the IVD market for hospital laboratories will benefit if this trend continues. promoting market expansion.
In-Vitro Diagnostics/IVD Market Players
Roche Diagnostics, Siemens Healthineers, Danaher Corporation, Abbott, and Thermo Fisher Scientific are the leading players in this market. Other players in this market are Johnson & Johnson, Becton, Dickinson and Company, Bio-Rad Laboratories, Sysmex Corporation, bioMérieux, Diasporic, Ortho Clinical Diagnostics, and QIAGEN N.V. are the key players in the In-Vitro Diagnostics/IVD market.
Who Should Buy? Or Key Stakeholders
- Hospitals
- Clinics
- Government Healthcare organisations
- Government healthcare departments
- Information technology companies
- Others
Key Takeaways
- The global In-Vitro Diagnostics/IVD market is expected to grow at 3.9% CAGR.
- On the basis of Product and service, the reagents & kits sector held the greatest share.
- On the basis of Technology, the immunoassay/immunochemistry sector will account for 31% of the IVD technologies market.
- On the basis of Application, Infectious disorders would account for 34.1 percent of the IVD market.
- On the basis of End use Industry, hospital laboratories will account for 47 percent of the IVD market.
- The IVD market in North America is well-established.
- The integration of artificial intelligence and machine learning into in-vitro diagnostics for enhanced accuracy and efficiency.
In-Vitro Diagnostics/IVD Market Regional Analysis
he In-Vitro Diagnostics/IVD market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
- North America: includes the US, Canada, Mexico
- Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
- Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
- South America: includes Brazil, Argentina and Rest of South America
- Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA
The IVD market in North America is well-established, with the United States serving as the region’s primary market. The growing per capita healthcare spending and the region’s technologically equipped healthcare infrastructure are driving growth in the North American industry. Different government associations’ initiatives are also expected to promote market expansion in the next years.
Key Market Segments: In-Vitro Diagnostics/IVD Market
In-Vitro Diagnostics/IVD Market by Product and Service, 2020-2029, (USD Million)
- Instrument
- Kits
In-Vitro Diagnostics/IVD Market by Application, 2020-2029, (USD Million)
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Infectious Diseases
In-Vitro Diagnostics/IVD Market by End User Industry, 2020-2029, (USD Million)
- Hospitals
- Clinical Laboratories
- Point-Of-Care Testing Centers
- Academic Institutes
- Patients
- Other
In-Vitro Diagnostics/IVD Market by Technology, 2020-2029, (USD Million)
- Immunoassay
- MDX
- Hematology
- Urinalysis
In-Vitro Diagnostics/IVD Market by Region, 2020-2029, (USD Million)
- North America
- Europe
- Asia Pacific
- South America
- Middle East And Africa
Important Countries In All Regions Are Covered.
Key Question Answered
- What is the current size of the In-Vitro Diagnostics/IVD market?
- What are the key factors influencing the growth of In-Vitro Diagnostics/IVD?
- What are the major applications for In-Vitro Diagnostics/IVD?
- Who are the major key players in the In-Vitro Diagnostics/IVD market?
- Which region will provide more business opportunities for In-Vitro Diagnostics/IVD in future?
- Which segment holds the maximum share of the In-Vitro Diagnostics/IVD market?
Table of Content
- Introduction
- Market Definition
- Market Segmentation
- Research Timelines
- Assumptions and Limitations
- Research Methodology
- Data Mining
- Secondary Research
- Primary Research
- Subject-Matter Experts’ Advice
- Quality Checks
- Final Review
- Data Triangulation
- Bottom-Up Approach
- Top-Down Approach
- Research Flow
- Data Sources
- Data Mining
- Executive Summary
- Market Overview
- Global In-Vitro Diagnostics Market Outlook
- Market Drivers
- Market Restraints
- Market Opportunities
- Impact of Covid-19 On Global In-Vitro Diagnostics Market
- Global In-Vitro Diagnostics Market Outlook
- Global In-Vitro Diagnostics Market by Product and Service, (USD Million)
- Instrument
- Kits
- Global In-Vitro Diagnostics Market by Technology, (USD Million)
- Immunoassay
- MDx
- Hematology
- Urinalysis
- Global In-Vitro Diagnostics Market by Application, (USD Million)
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Infectious Diseases
- Global In-Vitro Diagnostics Market by End User, (USD Million)
- Hospitals
- Clinical Laboratories
- Point of care testing centers
- Academic institutes
- Global In-Vitro Diagnostics Market by Region, (USD Million)
- Introduction
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
- South-East Asia
- Rest of Asia-Pacific
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Russia
- Rest of Europe
- South America
- Brazil
- Argentina
- Colombia
- Rest of South America
- Middle East and Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East and Africa
- Company Profiles* (Business Overview, Company Snapshot, Product and Service Offered, Recent Developments)
-
- Abbott Laboratories
- Becton, Dickinson and Company
- bioMérieux SA
- Bio-Rad Laboratories, Inc.
- Danaher Corporation (Beckman Coulter, Inc.)
- Hoffmann-La Roche AG
- Siemens AG
- QIAGEN N.V.
- Sysmex Corporation
- Thermo Fisher Scientific, Inc.
*The Company List Is Indicative
Â
LIST OF TABLES
TABLE 1Â Â Â Â Â Â Â Â Â GLOBAL IN-VITRO DIAGNOSTICS MARKET BY PRODUCT AND SERVICE (USD MILLIONS)
TABLE 2Â Â Â Â Â Â Â Â Â GLOBAL IN-VITRO DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS)
TABLE 3Â Â Â Â Â Â Â Â Â GLOBAL IN-VITRO DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS)
TABLE 4Â Â Â Â Â Â Â Â Â GLOBAL IN-VITRO DIAGNOSTICS MARKET BY END USER (USD MILLIONS)
TABLE 5Â Â Â Â Â Â Â Â Â GLOBAL IN-VITRO DIAGNOSTICS MARKET BY REGION (USD MILLIONS)
TABLE 6Â Â Â Â Â Â Â Â Â US IN-VITRO DIAGNOSTICS MARKET BY PRODUCT AND SERVICE (USD MILLIONS)
TABLE 7Â Â Â Â Â Â Â Â Â US IN-VITRO DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS)
TABLE 8Â Â Â Â Â Â Â Â Â US IN-VITRO DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS)
TABLE 9Â Â Â Â Â Â Â Â Â US IN-VITRO DIAGNOSTICS MARKET BY END USER (USD MILLIONS)
TABLE 10Â Â Â Â Â Â Â CANADA IN-VITRO DIAGNOSTICS MARKET BY PRODUCT AND SERVICE (USD MILLIONS)
TABLE 11Â Â Â Â Â Â Â CANADA IN-VITRO DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS)
TABLE 12Â Â Â Â Â Â Â CANADA IN-VITRO DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS)
TABLE 13Â Â Â Â Â Â Â CANADA IN-VITRO DIAGNOSTICS MARKET BY END USER (USD MILLIONS)
TABLE 14Â Â Â Â Â Â Â MEXICO IN-VITRO DIAGNOSTICS MARKET BY PRODUCT AND SERVICE (USD MILLIONS)
TABLE 15Â Â Â Â Â Â Â MEXICO IN-VITRO DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS)
TABLE 16Â Â Â Â Â Â Â MEXICO IN-VITRO DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS)
TABLE 17Â Â Â Â Â Â Â MEXICO IN-VITRO DIAGNOSTICS MARKET BY END USER (USD MILLIONS)
TABLE 18Â Â Â Â Â Â Â BRAZIL IN-VITRO DIAGNOSTICS MARKET BY PRODUCT AND SERVICE (USD MILLIONS)
TABLE 19Â Â Â Â Â Â Â BRAZIL IN-VITRO DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS)
TABLE 20Â Â Â Â Â Â Â BRAZIL IN-VITRO DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS)
TABLE 21Â Â Â Â Â Â Â BRAZIL IN-VITRO DIAGNOSTICS MARKET BY END USER (USD MILLIONS)
TABLE 22Â Â Â Â Â Â Â ARGENTINA IN-VITRO DIAGNOSTICS MARKET BY PRODUCT AND SERVICE (USD MILLIONS)
TABLE 23Â Â Â Â Â Â Â ARGENTINA IN-VITRO DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS)
TABLE 24Â Â Â Â Â Â Â ARGENTINA IN-VITRO DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS)
TABLE 25Â Â Â Â Â Â Â ARGENTINA IN-VITRO DIAGNOSTICS MARKET BY END USER (USD MILLIONS)
TABLE 26Â Â Â Â Â Â Â COLOMBIA IN-VITRO DIAGNOSTICS MARKET BY PRODUCT AND SERVICE (USD MILLIONS)
TABLE 27Â Â Â Â Â Â Â COLOMBIA IN-VITRO DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS)
TABLE 28Â Â Â Â Â Â Â COLOMBIA IN-VITRO DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS)
TABLE 29Â Â Â Â Â Â Â COLOMBIA IN-VITRO DIAGNOSTICS MARKET BY END USER (USD MILLIONS)
TABLE 30Â Â Â Â Â Â Â REST OF SOUTH AMERICA IN-VITRO DIAGNOSTICS MARKET BY PRODUCT AND SERVICE (USD MILLIONS)
TABLE 31Â Â Â Â Â Â Â REST OF SOUTH AMERICA IN-VITRO DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS)
TABLE 32Â Â Â Â Â Â Â REST OF SOUTH AMERICA IN-VITRO DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS)
TABLE 33Â Â Â Â Â Â Â REST OF SOUTH AMERICA IN-VITRO DIAGNOSTICS MARKET BY END USER (USD MILLIONS)
TABLE 34Â Â Â Â Â Â Â INDIA IN-VITRO DIAGNOSTICS MARKET BY PRODUCT AND SERVICE (USD MILLIONS)
TABLE 35Â Â Â Â Â Â Â INDIA IN-VITRO DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS)
TABLE 36Â Â Â Â Â Â Â INDIA IN-VITRO DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS)
TABLE 37Â Â Â Â Â Â Â INDIA IN-VITRO DIAGNOSTICS MARKET BY END USER (USD MILLIONS)
TABLE 38Â Â Â Â Â Â Â CHINA IN-VITRO DIAGNOSTICS MARKET BY PRODUCT AND SERVICE (USD MILLIONS)
TABLE 39Â Â Â Â Â Â Â CHINA IN-VITRO DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS)
TABLE 40Â Â Â Â Â Â Â CHINA IN-VITRO DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS)
TABLE 41Â Â Â Â Â Â Â CHINA IN-VITRO DIAGNOSTICS MARKET BY END USER (USD MILLIONS)
TABLE 42Â Â Â Â Â Â Â JAPAN IN-VITRO DIAGNOSTICS MARKET BY PRODUCT AND SERVICE (USD MILLIONS)
TABLE 43Â Â Â Â Â Â Â JAPAN IN-VITRO DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS)
TABLE 44Â Â Â Â Â Â Â JAPAN IN-VITRO DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS)
TABLE 45Â Â Â Â Â Â Â JAPAN IN-VITRO DIAGNOSTICS MARKET BY END USER (USD MILLIONS)
TABLE 46Â Â Â Â Â Â Â SOUTH KOREA IN-VITRO DIAGNOSTICS MARKET BY PRODUCT AND SERVICE (USD MILLIONS)
TABLE 47Â Â Â Â Â Â Â SOUTH KOREA IN-VITRO DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS)
TABLE 48Â Â Â Â Â Â Â SOUTH KOREA IN-VITRO DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS)
TABLE 49Â Â Â Â Â Â Â SOUTH KOREA IN-VITRO DIAGNOSTICS MARKET BY END USER (USD MILLIONS)
TABLE 50Â Â Â Â Â Â Â AUSTRALIA IN-VITRO DIAGNOSTICS MARKET BY PRODUCT AND SERVICE (USD MILLIONS)
TABLE 51Â Â Â Â Â Â Â AUSTRALIA IN-VITRO DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS)
TABLE 52Â Â Â Â Â Â Â AUSTRALIA IN-VITRO DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS)
TABLE 53Â Â Â Â Â Â Â AUSTRALIA IN-VITRO DIAGNOSTICS MARKET BY END USER (USD MILLIONS)
TABLE 54Â Â Â Â Â Â Â SOUTH-EAST ASIA IN-VITRO DIAGNOSTICS MARKET BY PRODUCT AND SERVICE (USD MILLIONS)
TABLE 55Â Â Â Â Â Â Â SOUTH-EAST ASIA IN-VITRO DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS)
TABLE 56Â Â Â Â Â Â Â SOUTH-EAST ASIA IN-VITRO DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS)
TABLE 57Â Â Â Â Â Â Â SOUTH-EAST ASIA IN-VITRO DIAGNOSTICS MARKET BY END USER (USD MILLIONS)
TABLE 58Â Â Â Â Â Â Â REST OF ASIA PACIFIC IN-VITRO DIAGNOSTICS MARKET BY PRODUCT AND SERVICE (USD MILLIONS)
TABLE 59Â Â Â Â Â Â Â REST OF ASIA PACIFIC IN-VITRO DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS)
TABLE 60Â Â Â Â Â Â Â REST OF ASIA PACIFIC IN-VITRO DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS)
TABLE 61Â Â Â Â Â Â Â REST OF ASIA PACIFIC IN-VITRO DIAGNOSTICS MARKET BY END USER (USD MILLIONS)
TABLE 62Â Â Â Â Â Â Â GERMANY IN-VITRO DIAGNOSTICS MARKET BY PRODUCT AND SERVICE (USD MILLIONS)
TABLE 63Â Â Â Â Â Â Â GERMANY IN-VITRO DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS)
TABLE 64Â Â Â Â Â Â Â GERMANY IN-VITRO DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS)
TABLE 65Â Â Â Â Â Â Â GERMANY IN-VITRO DIAGNOSTICS MARKET BY END USER (USD MILLIONS)
TABLE 66Â Â Â Â Â Â Â UK IN-VITRO DIAGNOSTICS MARKET BY PRODUCT AND SERVICE (USD MILLIONS)
TABLE 67Â Â Â Â Â Â Â UK IN-VITRO DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS)
TABLE 68Â Â Â Â Â Â Â UK IN-VITRO DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS)
TABLE 69Â Â Â Â Â Â Â UK IN-VITRO DIAGNOSTICS MARKET BY END USER (USD MILLIONS)
TABLE 70Â Â Â Â Â Â Â FRANCE IN-VITRO DIAGNOSTICS MARKET BY PRODUCT AND SERVICE (USD MILLIONS)
TABLE 71Â Â Â Â Â Â Â FRANCE IN-VITRO DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS)
TABLE 72Â Â Â Â Â Â Â FRANCE IN-VITRO DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS)
TABLE 73Â Â Â Â Â Â Â FRANCE IN-VITRO DIAGNOSTICS MARKET BY END USER (USD MILLIONS)
TABLE 74Â Â Â Â Â Â Â ITALY IN-VITRO DIAGNOSTICS MARKET BY PRODUCT AND SERVICE (USD MILLIONS)
TABLE 75Â Â Â Â Â Â Â ITALY IN-VITRO DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS)
TABLE 76Â Â Â Â Â Â Â ITALY IN-VITRO DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS)
TABLE 77Â Â Â Â Â Â Â ITALY IN-VITRO DIAGNOSTICS MARKET BY END USER (USD MILLIONS)
TABLE 78Â Â Â Â Â Â Â SPAIN IN-VITRO DIAGNOSTICS MARKET BY PRODUCT AND SERVICE (USD MILLIONS)
TABLE 79Â Â Â Â Â Â Â SPAIN IN-VITRO DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS)
TABLE 80Â Â Â Â Â Â Â SPAIN IN-VITRO DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS)
TABLE 81Â Â Â Â Â Â Â SPAIN IN-VITRO DIAGNOSTICS MARKET BY END USER (USD MILLIONS)
TABLE 82Â Â Â Â Â Â Â RUSSIA IN-VITRO DIAGNOSTICS MARKET BY PRODUCT AND SERVICE (USD MILLIONS)
TABLE 83Â Â Â Â Â Â Â RUSSIA IN-VITRO DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS)
TABLE 84Â Â Â Â Â Â Â RUSSIA IN-VITRO DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS)
TABLE 85Â Â Â Â Â Â Â RUSSIA IN-VITRO DIAGNOSTICS MARKET BY END USER (USD MILLIONS)
TABLE 86Â Â Â Â Â Â Â REST OF EUROPE IN-VITRO DIAGNOSTICS MARKET BY PRODUCT AND SERVICE (USD MILLIONS)
TABLE 87Â Â Â Â Â Â Â REST OF EUROPE IN-VITRO DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS)
TABLE 88Â Â Â Â Â Â Â REST OF EUROPE IN-VITRO DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS)
TABLE 89Â Â Â Â Â Â Â REST OF EUROPE IN-VITRO DIAGNOSTICS MARKET BY END USER (USD MILLIONS)
TABLE 90Â Â Â Â Â Â Â UAE IN-VITRO DIAGNOSTICS MARKET BY PRODUCT AND SERVICE (USD MILLIONS)
TABLE 91Â Â Â Â Â Â Â UAE IN-VITRO DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS)
TABLE 92Â Â Â Â Â Â Â UAE IN-VITRO DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS)
TABLE 93Â Â Â Â Â Â Â UAE IN-VITRO DIAGNOSTICS MARKET BY END USER (USD MILLIONS)
TABLE 94Â Â Â Â Â Â Â SAUDI ARABIA IN-VITRO DIAGNOSTICS MARKET BY PRODUCT AND SERVICE (USD MILLIONS)
TABLE 95Â Â Â Â Â Â Â SAUDI ARABIA IN-VITRO DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS)
TABLE 96Â Â Â Â Â Â Â SAUDI ARABIA IN-VITRO DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS)
TABLE 97Â Â Â Â Â Â Â SAUDI ARABIA IN-VITRO DIAGNOSTICS MARKET BY END USER (USD MILLIONS)
TABLE 98Â Â Â Â Â Â Â SOUTH AFRICA IN-VITRO DIAGNOSTICS MARKET BY PRODUCT AND SERVICE (USD MILLIONS)
TABLE 99Â Â Â Â Â Â Â SOUTH AFRICA IN-VITRO DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS)
TABLE 100Â Â Â Â Â SOUTH AFRICA IN-VITRO DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS)
TABLE 101Â Â Â Â Â SOUTH AFRICA IN-VITRO DIAGNOSTICS MARKET BY END USER (USD MILLIONS)
TABLE 102Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA IN-VITRO DIAGNOSTICS MARKET BY PRODUCT AND SERVICE (USD MILLIONS)
TABLE 103Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA IN-VITRO DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS)
TABLE 104Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA IN-VITRO DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS)
TABLE 105Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA IN-VITRO DIAGNOSTICS MARKET BY END USER (USD MILLIONS)
LIST OF FIGURES
FIGURE 1Â Â Â Â Â Â MARKET DYNAMICS
FIGURE 2Â Â Â Â Â Â Â Â MARKET SEGMENTATION
FIGURE 3Â Â Â Â Â Â Â Â REPORT TIMELINES: YEARS CONSIDERED
FIGURE 4Â Â Â Â Â Â Â Â DATA TRIANGULATION
FIGURE 5Â Â Â Â Â Â Â Â BOTTOM-UP APPROACH
FIGURE 6Â Â Â Â Â Â Â Â TOP-DOWN APPROACH
FIGURE 7Â Â Â Â Â Â Â Â RESEARCH FLOW
FIGURE 8Â Â Â Â Â Â Â Â GLOBAL IN-VITRO DIAGNOSTICS MARKET BY TECHNOLOGY, USD MILLION, 2019-2028
FIGURE 9Â Â Â Â Â Â Â Â GLOBAL IN-VITRO DIAGNOSTICS MARKET BY END USER, USD MILLION, 2019-2028
FIGURE 10Â Â Â Â Â Â GLOBAL IN-VITRO DIAGNOSTICS MARKET BY PRODUCT AND SERVICE, USD MILLION, 2019-2028
FIGURE 11Â Â Â Â Â Â GLOBAL IN-VITRO DIAGNOSTICS MARKET BY APPLICATION, USD MILLION, 2019-2028
FIGURE 12Â Â Â Â Â Â GLOBAL IN-VITRO DIAGNOSTICS MARKET BY REGION, USD MILLION, 2019-2028
FIGURE 13      PORTER’S FIVE FORCES MODEL
FIGURE 14Â Â Â Â Â Â GLOBAL IN-VITRO DIAGNOSTICS MARKET BY TECHNOLOGY, 2020
FIGURE 15Â Â Â Â Â Â GLOBAL IN-VITRO DIAGNOSTICS MARKET BY END USER 2020
FIGURE 16Â Â Â Â Â Â GLOBAL IN-VITRO DIAGNOSTICS MARKET BY PRODUCT AND SERVICE 2020
FIGURE 17Â Â Â Â Â Â GLOBAL IN-VITRO DIAGNOSTICS MARKET BY APPLICATION 2020
FIGURE 18Â Â Â Â Â Â IN-VITRO DIAGNOSTICS MARKET BY REGION 2020
FIGURE 19Â Â Â Â Â Â MARKET SHARE ANALYSIS
FIGURE 20Â Â Â Â Â Â ABBOTT LABORATORIES: COMPANY SNAPSHOT
FIGURE 21Â Â Â Â Â Â BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
FIGURE 22      BIOMÉRIEUX SA: COMPANY SNAPSHOT
FIGURE 23Â Â Â Â Â Â BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
FIGURE 24Â Â Â Â Â Â DANAHER CORPORATION (BECKMAN COULTER, INC.): COMPANY SNAPSHOT
FIGURE 25Â Â Â Â Â Â F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT
FIGURE 26Â Â Â Â Â Â SIEMENS AG: COMPANY SNAPSHOT
FIGURE 27Â Â Â Â Â Â QIAGEN N.V.: COMPANY SNAPSHOT
FIGURE 28Â Â Â Â Â Â SYSMEX CORPORATION: COMPANY SNAPSHOT
FIGURE 29Â Â Â Â Â Â THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
FAQ
The In-vitro diagnostics market size had crossed USD 95.16 billion in 2020 and will observe a CAGR of more than 3.9% up to 2029 driven by the rising technological advancements.
North America held more than 43% of the In-vitro diagnostics market revenue share in 2021 and will witness expansion. The IVD market in North America is well-established, with the United States serving as the region’s primary market. The growing per capita healthcare spending and the region’s technologically equipped healthcare infrastructure are driving growth in the North American industry.
The IVD market is characterized by intense competitiveness and is changing rapidly with automation, AI and advanced data analytics. One of the drivers of the In-Vitro diagnostics industry is the shift from centralized to point of care testing.
North America held the highest share of the global In-vitro diagnostics market. The IVD market in North America is well-established, with the United States serving as the region’s primary market. The growing per capita healthcare spending and the region’s technologically equipped healthcare infrastructure are driving growth in the North American industry.
In-Depth Database
Our Report’s database covers almost all topics of all regions over the Globe.
Recognised Publishing Sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales
support.
Safe & Secure
Complete secure payment
process.